This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Astrazeneca Ab. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Michael Glen Overstreet: Innovator in Cancer Treatment
Introduction
Michael Glen Overstreet is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of cancer treatment through his innovative work. His research focuses on the development of advanced therapeutic methods that utilize chimeric antigen receptors.
Latest Patents
Overstreet holds a patent for "Compositions and methods of treating cancer with chimeric antigen receptors." This patent relates to compositions and methods for treating cancer using armored chimeric antigen receptor cells. His work in this area represents a promising advancement in cancer therapies.
Career Highlights
Overstreet is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca allows him to contribute to groundbreaking research and development in the pharmaceutical industry. His expertise in cancer treatment has positioned him as a valuable asset in the field.
Collaborations
Throughout his career, Overstreet has collaborated with esteemed colleagues, including Gordon Moody and Maria Letizia Giardino Torchia. These collaborations have fostered an environment of innovation and have led to significant advancements in cancer treatment methodologies.
Conclusion
Michael Glen Overstreet's contributions to cancer treatment through his patented innovations highlight his dedication to improving patient outcomes. His work continues to inspire advancements in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile